| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Trial |
This study aimed to investigate the relationship between skeletal muscle, fibre type composition, functional respiratory impairment and exercise tolerance in patients with moderate to severe chronic obstructive pulmonary disease (COPD). A group of 22 COPD patients and 10 healthy control subjects were studied. In COPD patients, vital capacity (VC) and forced expiratory volume in one second (FEV1) were reduced to 79% and 51%, respectively. Diffusion indices (transfer factor of the lung for carbon monoxide (TL,CO) and carbon monoxide transfer coefficient (KCO)) were also reduced. Arterial oxygen tension (Pa,O2) was normal or slightly altered. A maximal exercise test was performed and anaerobic threshold was calculated. Muscle samples from vastus lateralis were obtained by needle biopsy. Myosin heavy chain (MHC) and light chain (MLC) isoforms were separated by gel electrophoresis and quantified by densitometry. MHC isoforms were considered as molecular markers of fibre types. The proportion of the fast MHC-2B isoform was increased in COPD patients. TL,CO, KCO, VC and FEV1 were positively correlated with slow MHC isoform content. TL,CO and KCO were also negatively correlated with the content of the fast MHC-2B isoform. No correlation was found between exercise parameters and MHC isoform composition. The co-ordinated expression between MHC and MLC isoforms was altered in COPD patients. We conclude that reduced oxygen availability, probably in combination with muscle disuse, may determine muscle alterations in chronic obstructive pulmonary disease patients. The altered correlations between myosin heavy chain and light chain isoforms suggest that co-ordinated protein expression is lost in chronic obstructive pulmonary disease muscles.
This article has been cited by other articles:
|
|
 |
|
  A. H. Remels, H. R. Gosker, P. Schrauwen, R. C. Langen, and A. M. Schols Peroxisome proliferator-activated receptors: a therapeutic target in COPD? Eur. Respir. J., March 1, 2008; 31(3): 502 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. R Gosker, M. P Zeegers, E. F M Wouters, and A. M W J Schols Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis Thorax, November 1, 2007; 62(11): 944 - 949. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Jelic and T. H. Le Jemtel Diagnostic Usefulness of B-Type Natriuretic Peptide and Functional Consequences of Muscle Alterations in COPD and Chronic Heart Failure. Chest, October 1, 2006; 130(4): 1220 - 1230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P Mattson and J. C Martin Emphysema-induced reductions in locomotory skeletal muscle contractile function Exp Physiol, July 1, 2005; 90(4): 519 - 525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B Polla, G D'Antona, R Bottinelli, and C Reggiani Respiratory muscle fibres: specialisation and plasticity Thorax, September 1, 2004; 59(9): 808 - 817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.P. Mattson, M.D. Delp, and D.C. Poole Differential effects of emphysema on skeletal muscle fibre atrophy in hamsters Eur. Respir. J., May 1, 2004; 23(5): 703 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.P.K.J. Engelen, M. Orozco-Levi, N.E.P. Deutz, E. Barreiro, N. Hernandez, E.F.M. Wouters, J. Gea, and A.M.W.J. Schols Glutathione and glutamate levels in the diaphragm of patients with chronic obstructive pulmonary disease Eur. Respir. J., April 1, 2004; 23(4): 545 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Montes de Oca, S. H. Torres, J. G. Loyo, F. Vazquez, N. Hernandez, B. Anchustegui, and J. J. Puigbo Exercise Performance and Skeletal Muscles in Patients With Advanced Chagas Disease Chest, April 1, 2004; 125(4): 1306 - 1314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Richardson, B. T. Leek, T. P. Gavin, L. J. Haseler, S. R. D. Mudaliar, R. Henry, O. Mathieu-Costello, and P. D. Wagner Reduced Mechanical Efficiency in Chronic Obstructive Pulmonary Disease but Normal Peak VO2 with Small Muscle Mass Exercise Am. J. Respir. Crit. Care Med., January 1, 2004; 169(1): 89 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. C. Selvadurai, J. Allen, T. Sachinwalla, J. Macauley, C. J. Blimkie, and P. P. Van Asperen Muscle Function and Resting Energy Expenditure in Female Athletes with Cystic Fibrosis Am. J. Respir. Crit. Care Med., December 15, 2003; 168(12): 1476 - 1480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.T. Jagoe and M.P.K.J. Engelen Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease Eur. Respir. J., November 2, 2003; 22(46_suppl): 52s - 63s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.M.W.J. Schols Nutritional and metabolic modulation in chronic obstructive pulmonary disease management Eur. Respir. J., November 2, 2003; 22(46_suppl): 81s - 86s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E F M Wouters Chronic obstructive pulmonary disease * 5: Systemic effects of COPD Thorax, December 1, 2002; 57(12): 1067 - 1070. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W M H Behan, D W Cossar, H A Madden, and I C McKay Validation of a simple, rapid, and economical technique for distinguishing type 1 and 2 fibres in fixed and frozen skeletal muscle J. Clin. Pathol., May 1, 2002; 55(5): 375 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.R. Gosker, H. van Mameren, P.J. van Dijk, M.P.K.J. Engelen, G.J. van der Vusse, E.F.M. Wouters, and A.M.W.J. Schols Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease Eur. Respir. J., April 1, 2002; 19(4): 617 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. W. Liesker, P. J. Wijkstra, N. H. T. Ten Hacken, G. H. Koeter, D. S. Postma, and H. A. M. Kerstjens A Systematic Review of the Effects of Bronchodilators on Exercise Capacity in Patients With COPD Chest, February 1, 2002; 121(2): 597 - 608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.G. Gea, M. Pasto, M.A. Carmona, M. Orozco-Levi, J. Palomeque, and J. Broquetas Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease Eur. Respir. J., May 1, 2001; 17(5): 939 - 945. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. K. J. ENGELEN, A. M. W. J. SCHOLS, J. D. DOES, H. R. GOSKER, N. E. P. DEUTZ, and E. F. M. WOUTERS Exercise-Induced Lactate Increase in Relation to Muscle Substrates in Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1697 - 1704. [Abstract] [Full Text]
|
|
|
|
|
|
F. Maltais, P. LeBlanc, F. Whittom, C. Simard, K. Marquis, M. Bélanger, M.-J. Breton, and J. Jobin Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD Thorax, October 1, 2000; 55(10): 848 - 853. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. R Gosker, E. F. Wouters, G. J van der Vusse, and A. M. Schols Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1033 - 1047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. F.M. Wouters Nutrition and Metabolism in COPD Chest, May 1, 2000; 117(5_suppl_1): 274S - 280S. [Full Text] [PDF]
|
|
|
|
|
|
R. Casaburi Skeletal Muscle Function in COPD Chest, May 1, 2000; 117(5_suppl_1): 267S - 271S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. K. J. ENGELEN, A. M. W. J. SCHOLS, J. D. DOES, N. E. P. DEUTZ, and E. F. M. WOUTERS Altered Glutamate Metabolism Is Associated with Reduced Muscle Glutathione Levels in Patients with Emphysema Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 98 - 103. [Abstract] [Full Text]
|
|
|
|
|
|
Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease . A Statement of the American Thoracic Society and European Respiratory Society Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): S2 - 40. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
